SFARI presentations at INSAR 2018

James McPartland is an Associate Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is also the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials.

A number of presentations will be given by SFARI Investigators and SFARI staff at the International Society for Autism Research (INSAR) 2018 Annual Meeting in Rotterdam, Netherlands (May 9-12).

SFARI posters at INSAR 2018

A selection of these talks is highlighted below:

Mark H. Johnson, Ph.D. (Birkbeck College, University of London)
Keynote address:
Babies at-risk for autism: Assumptions, progress and prospects

James C. McPartland, Ph.D. (Yale University)
Oral session presentation:
The Autism Biomarkers Consortium for Clinical Trials: Study design and progress to interim analysis

Stephan Sanders, B.M.B.S., Ph.D. (University of California, San Francisco)
Oral session presentation:
Characterization of SCN2A haploinsufficiency in early neurodevelopment using transcriptomic analyses and systems biology

Frederick Shic, Ph.D. (Seattle Children’s Research Institute, University of Washington)
Oral session presentation:
The Autism Biomarkers Consortium for Clinical Trials: Eye tracking interim analyses

John Spiro, Ph.D. (Simons Foundation)
Sponsor presentation:
Simons Foundation update

Jennifer Tjernagel, M.S. (Simons Foundation)
Oral presentation (as part of the following Special Interest Group):
Promoting partnerships between patient advocacy groups and researchers to improve autism research

SFARI staff will also be presenting a number of posters about SFARI projects and resources, including the latest results from SPARK. Click here for more details.